Abstract:Prolonged hyperglycemia can alter retinal function, ultimately resulting in blindness. Adult zebrafish adults exposed to alternating conditions of 2% glucose/0% glucose display a 3× increase in blood sugar levels. After 4 weeks of treatment, electroretinograms (ERGs) were recorded from isolated, perfused, in vitro eyecups. Control animals were exposed to alternating 2% mannitol/0% mannitol (osmotic control) or to alternating water (0% glucose/0% glucose; handling control). Two types of ERGs were recorded: (1) … Show more
“…Lacking a blood-retinal barrier to hinder glucose delivery directly to neurons, in vitro neuroretinal cultures, ex vivo explants, and isolated eyecups have been used to test the effects of high glucose in the absence of vascular influence, with or without experimental supplementation of relevant cellular and metabolic stressors. In general, such studies indicate that short-term hyperglycemia is beneficial to photoreceptor integrity and electrophysiology, whereas chronic or long-term hyperglycemia increases susceptibility to a range of cellular stressors present in culture or established within the systemic background prior to isolation of the retina (Han et al, 2013;Layton, 2015;Matteucci et al, 2015;Tanvir et al, 2018;Calbiague et al, 2019). Although research efforts to dissect effects of hyperglycemia in photoreceptors are gaining momentum, existing studies collectively suggest an extreme adaptability of these outer retinal neurons, and a need for precise control of hyperglycemic duration as well as the extracellular milieu to understand their role in early DR.…”
Section: Hyperglycemia and Hyperlipidemiamentioning
Based on clinical findings, diabetic retinopathy (DR) has traditionally been defined as a retinal microvasculopathy. Retinal neuronal dysfunction is now recognized as an early event in the diabetic retina before development of overt DR. While detrimental effects of diabetes on the survival and function of inner retinal cells, such as retinal ganglion cells and amacrine cells, are widely recognized, evidence that photoreceptors in the outer retina undergo early alterations in diabetes has emerged more recently. We review data from preclinical and clinical studies demonstrating a conserved reduction of electrophysiological function in diabetic retinas, as well as evidence for photoreceptor loss. Complementing in vivo studies, we discuss the ex vivo electroretinography technique as a useful method to investigate photoreceptor function in isolated retinas from diabetic animal models. Finally, we consider the possibility that early photoreceptor pathology contributes to the progression of DR, and discuss possible mechanisms of photoreceptor damage in the diabetic retina, such as enhanced production of reactive oxygen species and other inflammatory factors whose detrimental effects may be augmented by phototransduction.
“…Lacking a blood-retinal barrier to hinder glucose delivery directly to neurons, in vitro neuroretinal cultures, ex vivo explants, and isolated eyecups have been used to test the effects of high glucose in the absence of vascular influence, with or without experimental supplementation of relevant cellular and metabolic stressors. In general, such studies indicate that short-term hyperglycemia is beneficial to photoreceptor integrity and electrophysiology, whereas chronic or long-term hyperglycemia increases susceptibility to a range of cellular stressors present in culture or established within the systemic background prior to isolation of the retina (Han et al, 2013;Layton, 2015;Matteucci et al, 2015;Tanvir et al, 2018;Calbiague et al, 2019). Although research efforts to dissect effects of hyperglycemia in photoreceptors are gaining momentum, existing studies collectively suggest an extreme adaptability of these outer retinal neurons, and a need for precise control of hyperglycemic duration as well as the extracellular milieu to understand their role in early DR.…”
Section: Hyperglycemia and Hyperlipidemiamentioning
Based on clinical findings, diabetic retinopathy (DR) has traditionally been defined as a retinal microvasculopathy. Retinal neuronal dysfunction is now recognized as an early event in the diabetic retina before development of overt DR. While detrimental effects of diabetes on the survival and function of inner retinal cells, such as retinal ganglion cells and amacrine cells, are widely recognized, evidence that photoreceptors in the outer retina undergo early alterations in diabetes has emerged more recently. We review data from preclinical and clinical studies demonstrating a conserved reduction of electrophysiological function in diabetic retinas, as well as evidence for photoreceptor loss. Complementing in vivo studies, we discuss the ex vivo electroretinography technique as a useful method to investigate photoreceptor function in isolated retinas from diabetic animal models. Finally, we consider the possibility that early photoreceptor pathology contributes to the progression of DR, and discuss possible mechanisms of photoreceptor damage in the diabetic retina, such as enhanced production of reactive oxygen species and other inflammatory factors whose detrimental effects may be augmented by phototransduction.
“…14,15 Hyperglycemic zebrafish, caused by high glucose incubation or toxin-induced loss of beta cells, showed retinal thinning and vasculature changes, as well as disruption of cone cells. [16][17][18] However, there was no evidence for neovascularization, perhaps due to limited duration of the treatments. Thus far there have been no zebrafish models for PDR, or for earlier stages of DR based on genetically induced diabetes.…”
PURPOSE. Diabetic retinopathy (DR) is a leading cause of vision impairment and blindness worldwide in the working-age population, and the incidence is rising. Until now it has been difficult to define initiating events and disease progression at the molecular level, as available diabetic rodent models do not present the full spectrum of neural and vascular pathologies. Zebrafish harboring a homozygous mutation in the pancreatic transcription factor pdx1 were previously shown to display a diabetic phenotype from larval stages through adulthood. In this study, pdx1 mutants were examined for retinal vascular and neuronal pathology to demonstrate suitability of these fish for modeling DR.
METHODS.Vessel morphology was examined in pdx1 mutant and control fish expressing the fli1a:EGFP transgene. We further characterized vascular and retinal phenotypes in mutants and controls using immunohistochemistry, histology, and electron microscopy. Retinal function was assessed using electroretinography.
RESULTS.Pdx1 mutants exhibit clear vascular phenotypes at 2 months of age, and disease progression, including arterial vasculopenia, capillary tortuosity, and hypersprouting, could be detected at stages extending over more than 1 year. Neural-retinal pathologies are consistent with photoreceptor dysfunction and loss, but do not progress to blindness.
CONCLUSIONS.This study highlights pdx1 mutant zebrafish as a valuable complement to rodent and other mammalian models of DR, in particular for research into the mechanistic interplay of diabetes with vascular and neuroretinal disease. They are furthermore suited for molecular studies to identify new targets for treatment of early as well as late DR.
“…The amplitude of the native photopic (white light) ERG was found to be significantly lower in hyperglycemic fish compared to mannitol-treated fish, which act as a control for osmotic changes. B-wave parameters were also reduced in response to spectral ERG stimuli, indicating cone-pathway deficits [ 145 ]. Hyperglycemia also significantly reduced the amplitude of the d-wave, which is thought to be derived from the OFF-bipolar cells.…”
Section: Robust Endpoints For Retinal Neuroprotection Studies In Zmentioning
Neurodegenerative retinal diseases, such as glaucoma and diabetic retinopathy, involve a gradual loss of neurons in the retina as the disease progresses. Central nervous system neurons are not able to regenerate in mammals, therefore, an often sought after course of treatment for neuronal loss follows a neuroprotective or regenerative strategy. Neuroprotection is the process of preserving the structure and function of the neurons that have survived a harmful insult; while regenerative approaches aim to replace or rewire the neurons and synaptic connections that were lost, or induce regrowth of damaged axons or dendrites. In order to test the neuroprotective effectiveness or the regenerative capacity of a particular agent, a robust experimental model of retinal neuronal damage is essential. Zebrafish are being used more often in this type of study because their eye structure and development is well-conserved between zebrafish and mammals. Zebrafish are robust genetic tools and are relatively inexpensive to maintain. The large array of functional and behavioral tests available in zebrafish makes them an attractive model for neuroprotection studies. Some common insults used to model retinal disease and study neuroprotection in zebrafish include intense light, chemical toxicity and mechanical damage. This review covers the existing retinal neuroprotection and regeneration literature in the zebrafish and highlights their potential for future studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.